logo-loader
RNS
Cavendish PLC

Cavendish Financial - AGM Trading Statement

RNS Number : 0410O
Cavendish Financial PLC
29 September 2023
 

29 September 2023

For immediate Release

 

Cavendish Financial plc ("Cavendish" or the "Group")

AGM Trading Statement

Cavendish Financial plc announces the following update ahead of its Annual General Meeting to be held today at 10.00 am:

On 8 September, finnCap Group plc and Cenkos Securities plc completed their merger to create Cavendish Financial plc, a full-service investment bank for ambitious growth companies.

The combined operation consists of just under 200 people operating from its headquarters in One Bartholomew Close, London and its Scottish office in Edinburgh.   With 220 quoted clients, the Group has the largest retained client base amongst UK small and midcap investment banks, making it the go-to financial advisory firm for growth and investment companies.   In addition to equity capital markets, Cavendish has expertise in M&A, debt advisory and private growth capital. The Group also has a strong global reach through its membership of Oaklins, an international advisory network.

 

Since the merger, the Group has relocated all of the London based Cenkos team to its London headquarters, launched the new operating brand Cavendish, centralised trading onto a single platform and made substantial progress with its IT integration.  The integration of the operations team, a key part of delivering the synergies is also nearing completion.  The Group will provide a further update on synergy realisation within its inaugural interim results expected to be announced in December.

 

Trading across the City has been quiet during the Summer, but since merger completion the Group has already announced a number of significant transactions which will close in the coming months including acting as sole adviser to Round Hill Royalty Fund Limited on its offer from Concord Cadence Limited, fundraisings for Haydale Graphene PLC and Shield Therapeutics plc and obtaining key regulatory clearances for the equity financing of Allergy Therapeutics by ZQ Capital and Southern Fox.

 


Contacts:

 

Cavendish Financial plc                                                                                                Tel: +44 (0)20 7220 0500

John Farrugia, co-CEO

Julian Morse, co-CEO

 

Grant Thorton UK LLP (Nominated Adviser to Cavendish)                                   Tel: +44 (0)20 7383 5100

Philip Secrett/Samantha Harrison/Samuel Littler

Hudson Sandler (PR adviser to Cavendish)

Dan de Belder                                                                                                                 Tel: +44 (0) 7977 927142

Rebekah Chapman                                                                                                         Tel: +44 (0) 7702 596674

 

 

About Cavendish 

Cavendish is a UK champion for ambitious growth and investment companies. The Group is trusted by public and private companies, operating across industry sectors, to deliver expert services in equity capital markets, M&A, debt advisory and growth capital.

 

Cavendish has offices in the City of London and Edinburgh and has a global reach through its membership of Oaklins. Cavendish Financial plc is quoted on AIM.

 

For more information on Cavendish, please visit www.cavendish.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUWROROUUKUAR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

3 days, 10 hours ago

Holding(s) in Company

6 days, 4 hours ago

Director Dealing

1 week ago

Half Year Trading Update

on 10/13/2026

Director Dealing

on 09/18/2026

4 min read